Goals and Objectives (Each lecture will have its own complete set of goals and objectives)
At the end of this course, the learner will be able to:
- Explain risk factors and warning signs for suicide;
- Discuss the complications of a busy schedule, use of electronics, and problems related to sleep medications;
- Discuss challenges with defining “treatment resistant depression”;
- Compare and contrast antidepressant medications with regards to their safety in pregnancy;
- Identify diagnoses/symptoms in the pediatric population that may lead a prescriber to consider an antipsychotic;
- Describe communication strategies employed by the interprofessional team to advance psychiatric care and;
- Describe the impact of stigma on health outcomes
Andrea Bailey, LCSW, Lead Suicide Prevention Coordinator, William S. Middleton VA Hospital, Madison, WI
Catie Beck, MSW, APSW, Access Community Health, Madison, WI
Jennifer Brandt, CPNP, PMHNP-BC, Group Health Cooperative, Madison, WI
Ann Ebert, PharmD, Clinical Pharmacy Specialist for Perinatology, UnityPoint Health-Meriter and Clinical Assistant Professor, UW-Madison School of Pharmacy, Madison, WI
Rachel Edwards, RN-BC MSN, Nurse Manager, Behavioral Health, UW-Health, Madison, WI
Jennifer Fiegel-Newlon, DNP, PMHNP-BC, FNP-BC, APNP, Clinical Assistant Professor, UW-Madison-School of Nursing, Madison, WI
Casey Gallimore, PharmD, Associate Professor (CHS), UW-Madison, School of Pharmacy, Madison, WI
Michael M. Miller, MD, FASAM, FAPA, Medical Director, Herrington Recovery Center, Rogers Memorial Hospital, Oconomowoc, WI
Gina Bryan, DNP, RN, Clinical Professor, Psychiatric-Mental Health Certificate Coordinator, UW-Madison, School of Nursing, Madison, WI
Eric Buxton, PhD, Clinical Associate Professor, Division Chair, Division of Pharmacy Professional Development, UW-Madison School of Pharmacy, Madison, WI
Casey Gallimore, PharmD, Associate Professor (CHS), UW-Madison School of Pharmacy, Madison, WI
Policy on Faculty and Sponsor Disclosure
It is the policy of the University of Wisconsin – Madison ICEP that the faculty, authors, planners, and other persons who may influence content of this activity disclose all relevant financial relationships with commercial interests in order to allow staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). Detailed disclosures will be made in the activity handout materials.
In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
Accreditation Council for Pharmacy Education (ACPE)
The University of Wisconsin-Madison ICEP designates this enduring knowledge-based activity for 12 hours (1.2 CEUs) of CPE credit. Credit can be earned by successfully completing the assessment (70% or better score) and evaluation. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. There will be no partial credit awarded for partial completion.
Enduring (home study): JA0000358-0000-19-072-H01-P
Release Date: 09/10/2019 Expiration Date: 9/10/2022
American Nurses Credentialing Center (ANCC) & Iowa Board of Nursing
The University of Wisconsin-Madison ICEP designates this enduring study activity for a maximum of 12 ANCC contact hours. (ANCC pharmacotherapeutic contact hours will be calculated and awarded as appropriate to meet the needs of advanced practice nurses.) The University of Wisconsin-Madison School of Nursing is Iowa Board of Nursing provider 350.
Continuing Education Units (CEUs)
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 1.2 CEUs or 12 hours.